|
Delayed
London S.E.
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
+0.65% | -29.32% |
| 14/12/17 | Vernalis : AGM Statement | PU |
| 14/12/17 | Vernalis PLC: AGM Statement | MW |
| 13/12/17 | Vernalis : enters into research collaboration with Daiichi Sankyo | PU |
| 13/12/17 | Vernalis : + Daiichi Sankyo Enter Collaboration | MW |
| 06/12/17 | Vernalis : and Servier Achieve Research Milestone in Third Oncology Collaboration | PU |
| Director | Title | Age | Since |
|---|---|---|---|
Todd Davis
BRD | Director/Board Member | 65 | 04/12/2022 |
Octavio Espinoza
BRD | Director/Board Member | 56 | 31/10/2022 |
Andrew Reardon
BRD | Director/Board Member | 52 | 31/10/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.65% | - | - | 0 | |
| +0.61% | +0.67% | -1.32% | +26.94% | 45.91B | |
| -0.32% | +4.61% | +43.90% | +26.98% | 44.25B | |
| -4.36% | -5.66% | +338.30% | +516.88% | 41.99B | |
| +0.46% | -0.83% | +6.38% | +73.76% | 39.58B | |
| -0.17% | -3.22% | +10.29% | +38.69% | 31.08B | |
| -0.65% | +5.14% | +25.61% | +120.17% | 17.21B | |
| +3.30% | -5.03% | - | - | 16.27B | |
| +2.28% | +7.70% | +21.66% | +38.82% | 14.96B | |
| +0.86% | +9.05% | +0.47% | -33.54% | 13.42B | |
| Average | +0.19% | +1.18% | +55.66% | +101.09% | 29.41B | |
| Weighted average by Cap. | -0.27% | +0.31% | +70.17% | +122.61% |
- Stock Market
- Stocks
- VER Stock
Select your edition
All financial news and data tailored to specific country editions
